Cryptococcal Antigen Lateral Flow Assay Test Market Players:
- Kestrel Biosciences LIC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Alere Inc.
- BioMerieux
- Danaher Corporation
- Forsite Diagnostics
- Merck Millipore
- Qiagen
- Roche Diagnostics
- Hologic (Gen-Probe)
- Siemens Healthcare
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cryptococcal antigen lateral flow assay test is evaluated at USD 812.77 million.
The global cryptococcal antigen lateral flow assay test market size exceeded USD 785.21 million in 2025 and is set to expand at a CAGR of over 3.9%, surpassing USD 1.15 billion revenue by 2035.
Across 2026-2035, the cryptococcal antigen lateral flow assay test market in the Middle East and Africa is forecast to command a 34% share by 2035, attributable to intensified healthcare investments addressing high HIV/AIDS prevalence.
Key players in the market include Kestrel Biosciences LIC, Alere Inc., BioMerieux, Danaher Corporation, Forsite Diagnostics, Merck Millipore, Qiagen, Roche Diagnostics, Hologic (Gen-Probe), Siemens Healthcare.
